Ignite Creation Date:
2024-05-06 @ 3:49 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04762407
Status:
COMPLETED
Last Update Posted:
2022-07-14
First Post:
2021-02-18
Brief Title:
A Study to Evaluate the Pharmacokinetics Safety and Tolerability of HCP1903
Sponsor:
Hanmi Pharmaceutical Company Limited
Organization:
Hanmi Pharmaceutical Company Limited
Study Overview
Official Title:
An Open-label Randomized Single-dose Crossover Study to Evaluate the Pharmacokinetics Safety and Tolerability of HCP1903 in Healthy Subjects
Status:
COMPLETED
Status Verified Date:
2022-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
An open-label randomized single-dose crossover study to evaluate the pharmacokinetics safety and tolerability of HCP1903 in healthy subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None